» Articles » PMID: 11695

Effect of Virus Infection on the Inflammatory Response. Depression of Macrophage Accumulation in Influenza-infected Mice

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1976 Nov 1
PMID 11695
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

To better define the mechanisms by which viruses depress immune function, the effect of influenza infection on the ability of macrophages to accumulate at sites of inflammation was determined. Mice were inoculated with virus, and their inflammatory response measured in vivo by counting the number of leukocytes which accumulated in the peritoneal cavity 2 days after an intraperitoneal injection of phytohemagglutinin. Mice infected with influenza had a 57% and 65% depression of total leukocyte and macrophage accumulation, respectively, as compared to the response of uninfected mice. In contrast, bacterial pneumonia did not produce a decrease in the macrophage response. This indicated that the depression was produced by the virus infection rather than being a nonspecific phenomenon accompanying any inflammatory focus in the lung. The in vitro chemotactic responsiveness of normal peritoneal macrophages incubated with infectious influenza virus was 53% of normal. These experiments suggest that influenza infection may depress a host's ability to mobilize macrophages to inflammatory sites in vivo by inhibiting their chemotactic responsiveness.

Citing Articles

Bacterial co-infections with SARS-CoV-2.

Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi H, Jeda A IUBMB Life. 2020; 72(10):2097-2111.

PMID: 32770825 PMC: 7436231. DOI: 10.1002/iub.2356.


Novel insights on the pulmonary vascular consequences of COVID-19.

Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie A Am J Physiol Lung Cell Mol Physiol. 2020; 319(2):L277-L288.

PMID: 32551862 PMC: 7414237. DOI: 10.1152/ajplung.00195.2020.


Prognostic accuracy of SIRS criteria and qSOFA score for in-hospital mortality among influenza patients in the emergency department.

Chu S, Seak C, Su T, Chaou C, Tseng H, Li C BMC Infect Dis. 2020; 20(1):385.

PMID: 32471385 PMC: 7256917. DOI: 10.1186/s12879-020-05102-7.


Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia.

Hanada S, Pirzadeh M, Carver K, Deng J Front Immunol. 2018; 9:2640.

PMID: 30505304 PMC: 6250824. DOI: 10.3389/fimmu.2018.02640.


Secondary Bacterial Infections Associated with Influenza Pandemics.

Morris D, Cleary D, Clarke S Front Microbiol. 2017; 8:1041.

PMID: 28690590 PMC: 5481322. DOI: 10.3389/fmicb.2017.01041.


References
1.
Snyderman R, Phillips J, Mergenhagen S . Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med. 1971; 134(5):1131-43. PMC: 2139022. DOI: 10.1084/jem.134.5.1131. View

2.
Henle W, LIEF F . Studies on the soluble antigen of influenza virus. I. The release of S antigen from elementary bodies by treatment with ether. Virology. 1956; 2(6):753-71. DOI: 10.1016/0042-6822(56)90056-3. View

3.
Martin C, Kunin C, GOTTLIEB L, FINLAND M . Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. AMA Arch Intern Med. 1959; 103(4):532-42. DOI: 10.1001/archinte.1959.00270040018002. View

4.
Sever J . Application of a microtechnique to viral serological investigations. J Immunol. 1962; 88:320-9. View

5.
Kantzler G, Lauteria S, Cusumano C, Lee J, Ganguly R, Waldman R . Immunosuppression during influenza virus infection. Infect Immun. 1974; 10(5):996-1002. PMC: 423051. DOI: 10.1128/iai.10.5.996-1002.1974. View